Biden Has Completed Radiation for Cancer
Digest more
Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with PSMA+ mHSPC.
An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.
Former President Joe Biden has finished a round of radiation therapy to treat the aggressive form of prostate cancer he was diagnosed with in May. The 82-year-old has been receiving treatment at